|Zubin Austin, Professor, Leslie Dan Faculty of Pharmacy, University of Toronto
February 2018: Received the University of Toronto’s President’s Research Impact Award for research that has a significant impact on society and the community.
- One of 7 recipients of this award, for my work related to integration of internationally educated health professionals in the Canadian workforce. With this award, also appointed to the University of Toronto’s Presidents Research Impact Academy, to advise the President and Vice-Provost about research-related matters and to optimize community engagement with our researchers.
June 2017: Received the Canadian Pharmacists’ Association award for Best Research Paper of 2016-2017. The paper that was selected was titled “Trust in Interprofessional Collaboration” and reported results of a qualitative study examining community pharmacists and family physicians and their relationships.
May 2018: Delivering keynote address to World Health Organization meeting on Regulation of the Health Professions in Geneva. Topic is Right-Touch Regulation and its application to regulatory bodies.
April 2018: Will be delivering keynote address to annual meeting of College of Physicians and Surgeons of Ontario on topic of assessment of competency in the health professions.
March 2018: Delivering keynote address to American Pharmacists’ Association annual meeting on topic of cultural competence in professional practice.
|Erica DiRuggiero, Director, Office of Global Public Health Education & Training, Dalla Lana School of Public Health, University of Toronto
Lisa Forman, Assistant Professor, Dalla Lana School of Public Health, University of Toronto
|Marc-Andre Gagnon, Associate Professor, School of Public Policy and Administration, Carleton University
|Paul Grootendorst, Associate Professor, Leslie Dan Faculty of Pharmacy, University of Toronto
2018 Member College of Reviewers, Canadian Institutes of Health Research
- Jayasundara K, Krahn M, Mamdani M, Hoch JS, Grootendorst P. Differences in Incremental Cost-Effectiveness Ratios for Common Versus Rare Conditions: A Case from Oncology PharmacoEconomics Open 2017; 1(3):167-173. doi:10.1007/s41669-017-0022-7.
- How Effective Is the Medicare Part D Drug Plan?
|Jillian Kohler, Professor, Leslie Dan Faculty of Pharmacy, University of Toronto
- MeTA: Pathways to Transparency, Accountability, and Access: Cross-Case Analysis and Review of Phase II
Taryn Vian and Jillian C. Kohler
WHO Publications (2016)
- Treating Health and Pharmaceutical Corruption: The Need for a Multistakeholder U.N. Partnership
Jillian Clare Kohler, Timothy Mackey
International Affairs Forum (Fall 2016, Volume 7, Issue 2)
- Corruption in the Pharmaceutical Sector: Diagnosing the challenges
Jillian Clare Kohler, Martha Gabriela Martinez, Michael Petkov, and James Sale
Transparency International UK, June 2016
- The disease of corruption: views on how to fight corruption to advance 21st century global health goals
Tim K. Mackey, Jillian Clare Kohler, William D. Savedoff, Frank Vogl, Maureen Lewis, James Sale, Joshua Michaud and Taryn Vian
BMC Medicine 2016 14:149
- Moscou K, Kohler JC, McGahan A. “Governance and pharmacovigilance in Brazil: a scoping review”. Journal of Pharmaceutical Policy and Practice 2016, 9:3
- Kohler JC, Mitsakakis N, Saadat F, Byng D, Martinez MG. “Does Pharmaceutical Pricing Transparency Matter? Examining Brazil’s Public Procurement System”. Globalization and Health 2015, 11:34
- Kohler JC, Martinez MG. “Participatory health councils and good governance: healthy democracy in Brazil?”. International Journal for Equity in Health 2015
|Trudo Lemmens, Professor, Faculty of Law, University of Toronto
- Shannon Gibson, Hamid Raziee & Trudo Lemmens, “Why the Shift? Taking a Closer Look at the Growing Interest in Niche Markets and Personalized Medicine” (2015) 7(1) World Medical & Health Policy 3-27.
- Trudo Lemmens & Shannon Gibson, “Decreasing the Data Deficit: Improving Post-Market Surveillance in Pharmaceutical Regulation” (2015) 59(4) McGill Law Journal 943-988.
- Shannon Gibson & Trudo Lemmens, “The Promise and Peril of Adapting the Regulatoy System to the Pharmacogenomic Context” (2015) 8(2) McGill Journal of Law & Health S145-230.
- Shannon Gibson & Trudo Lemmens, “Niche Markets and Evidence Assessment in Transition : A Critical Review of Proposed Drug Regulatory Reforms” (2014) 22(2) Medical Law Review 200-220
- Trudo Lemmens, “Pharmaceutical Knowledge Governance: A Human Rights Perspective” (2013) 41(1) Journal of Law, Medicine and Ethics 163-84.
- Trudo Lemmens & Candice Telfer, “Access to Information and the Right to Health: The Human Rights Case for Clinical Trials Transparency” (2012) 31(1) American Journal of Law & Medicine 63-112.
- Trudo Lemmens & Candice Telfer, “Clinical Trials Registration and Results Reporting and the Right to Health” in I. Glenn Cohen, The Globalization of Health Care: Legal and Ethical Issues (Cambridge (Mass): Oxford University Press, 2013) 255-271.
- Trudo Lemmens & Candice Telfer, “L’accès à l’information et le droit à la santé : la transparence des essais cliniques comme une obligation dans le contexte des droits de l’homme” in Louise Lalonde, ed., Le droit, vecteur de la gouvernance en santé? Défis théoriques et enjeux pratiques de l’accès aux soins de la santé (Sherbrooke: Éditions Revue de Droit de l’Université de Sherbrooke, 2012) 131-167.
- Simon Stern & Trudo Lemmens, “Legal Remedies for Medical Ghostwriting: Imposing Fraud Liability on Guest Authors of Ghostwritten Articles” (2011) 8(8) PLoS Medicine 1-8 (online: http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001070). (reprinted in: (2013) 22(4) Medical Writing (online: http://medicalwriting.emwa.org/article/show/pdf/953/).
- Karmela Krleza-Jeric, Trudo Lemmens, Ludovic Reveiz, Luis-Gabriel Cuervo & Lisa Bero, “Prospective Registration and Results Disclosure of Clinical Trials in the Americas: A Roadmap Toward Transparency” (2011) 30(1) Pan American Journal of Public Health 87-96. (online: http://issuu.com/researchforhealth/docs/2011_ictrp_americas).
Also in Spanish: “Registro prospectivo y comunicación de los resultados de los ensayos clínicos en la Región de las Américas” (2011) 30(1) Revisita Panamericana de Salud Publica 87-96. http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1908351
- Lori Ferris & Trudo Lemmens, “Governance of Conflict of Interest in Postmarketing Surveillance Research and the Canadian Drug Safety and Effectiveness Network” (2010) 4(2) Open Medicine (online: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=1704129)
|Joel Lexchin, Associate Professor, Faculty of Medicine, University of Toronto
2018 Member College of Reviewers, Canadian Institutes of Health Research
|Anita McGahan, Professor, Rotman School of Medicine, Munk School of Global Affairs, and Faculty of Medicine, University of Toronto
Awards and Grants:
2018-2020 Connaught Global Challenges Grant, University of Toronto, “Big Data – Local Impact – Healthy Lives: Building a Canadian Indigenous and African Health Informatics Research and Innovation Platform,” Principal Investigator with Laura Derkson, $250,000
- “Scaling Up Strategies that Work: Business Expertise Helps Expand Primary Care in Low- and Middle-Income Countries,” Kathryn Mossman, Onil Bhattacharyya, Anita McGahan and Will Mitchell, HBR.org (June, 2017) available at https://hbr.org/2017/06/expanding-the-reach-of-primary-care-in-developing-countries
- “Criteria to assess potential reverse innovations: Opportunities for shared learning between high and low income countries,” Onil Bhattacharyya, Diane Wu, Kathryn Mossman, Leigh Hayden, Pavanpreet Gill, Yu-Ling Cheng, Abdallah Daar, Dilip Soman, Christina Synowiec, Andrew D. Taylor, Joseph Wong, Max von Zedtwitz, Stanley Zlotkin, William Mitchell, and Anita McGahan, Globalization and Health (2017), 13:4, DOI: 10.1186/s12992-016-0225-1, January 25, available at https://goo.gl/lat5qc
- “Assessing health program performance in low- and middle-income countries: building a feasible, credible, and comprehensive framework”. Onil Bhattacharyya, Kathryn Mossman, John Ginther, Leigh Hayden, Raman Sohal, Jieun Cha, Ameya Bopardikar, John A. MacDonald, Himanshu Parikh, Ilan Shahin, Anita McGahan and Will Mitchell.
Globalization and Health. 2015. 11:51
- “Trans-National Scale-Up of Services in Global Health”. Ilan Shahin, Raman Sohal, John Ginther, Leigh Hayden, John A. MacDonald, Kathryn Mossman, Himanshu Parikh, Anita McGahan, Will Mitchell, Onil Bhattacharyya. Published: November 6, 2014. https://doi.org/10.1371/journal.pone.0110465
- “Investments in Pharmaceuticals Before and After TRIPS”. Margaret K. Kyle and Anita M. McGahan. Review of Economics and Statistics. Volume 94 | Issue 4 | November 2012. p.1157-1172. https://doi.org/10.1162/REST_a_00214
- Additional publication list (PDF)
|Tim Mackey, Assistant Professor, Department of Anesthesiology and Global Public Health, University of California, San Diego
2017–present: IEEE Standards Association, Co-Chair Supply Chain/Clinical Trials Technology Implementation Industry Connections Program
- Mackey TK, Kalyanam J, Katsuki T, Lanckriet G. Twitter-Based Detection of Illegal Online Sale of Prescription Opioid. Am J. Pub Health. 2017;107:1910-1915.
- Kalyanam J, Mackey TK. A Review of Digital Surveillance Methods and Approaches to Combat Prescription Drug Abuse. Curr Addict Rep. 2017; in press.
- Mackey TK, Kohler J, Lewis M, Vian T. Combating Corruption in Global Health. Sci Trans Med. 2017;9(402):eaaf9547.
- Annaloro J, Mackey TK. Policy Implications and Paths Forward for Post-Brexit Biotech. Nature Biotech. 2017;35:710-711.
- Tringale K, Marshall D, Mackey TK, Connor M, Murphy J, Hattangadi-Gluth J. Types and Distribution of Payments from Industry to Physicians in 2015. JAMA. 2017;317(17):1774-1784
- Mackey TK, Nayyar G. A Review of Existing and Emerging Digital Technologies to Combat the Global Fake Medicines Trade. Expert Opin Drug Saf. 2017;16(5):587-602.
- Cuomo RE, Seidman RL, Mackey TK. Country and Regional Variations in Purchase Price for Essential Cancer Medications. BMC Cancer. 2017; 17:566.
- Tim K. Mackey, Gaurvika Nayyar. Digital danger: a review of the global public health, patient safety and cybersecurity threats posed by illicit online pharmacies. British Medical Bulletin, Volume 118, Issue 1, 1 June 2016, Pages 110–126
- Janani Kalyanama, Takeo Katsuki, Gert R.G. Lanckriet, Tim K.Mackey. Exploring trends of nonmedical use of prescription drugs and polydrug abuse in the Twittersphere using unsupervised machine learning. Addictive Behaviors. Volume 65, February 2017, Pages 289-295
- Addional publication list (PDF)
2017 Media Activity:
Published article on STAT News First Opinion on WHO report and progress made towards combating fake medicines: https://www.statnews.com/2017/12/01/fake-medicines-who-surveillance/
2017 Research Coverage:
Media coverage of published research on using machine learning to detect illegal sales of opioids online in American Journal of Public Health. News Articles in Scientific American (https://www.scientificamerican.com/article/ai-scans-twitter-for-signs-of…); Salon (https://www.salon.com/2017/11/11/ai-scans-twitter-for-signs-of-opioid-abuse_partner/);
2017 Research Coverage:
Interview and radio news coverage on published research on global health corruption on BBC World Service Health Check segment: http://www.bbc.co.uk/programmes/p05b9q72;
2017 Media Activity:
Interview about views on block-chain technology and pharmaceutical supply chain in online and print version of Pharmaceutical Technology: http://www.pharmtech.com/node/339106
|Kathy Moscou, Adjunct Professor, Curriculum and Pedagogy and Research Affiliate, Brandon University
- Globalmed 2018 “Regulation, Markets, Health” Symposium in BENIN, March 25-29th.
“Pharmacogovernance in Kenya”. I am a panelist in the session, Leadership pharmaceutical systems. A conference paper, by the same title, has also been submitted.
|Nav Persaud, Associate Scientist, Li Ka Shing Knowledge Institute, Toronto, ON
- CLEAN Meds (Carefully seLected and Easily Accessible at No charge Medications)